Rhabdoviruses as vaccine platforms for infectious disease and cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rhabdoviruses as vaccine platforms for infectious disease and cancer
Authors
Keywords
-
Journal
Biotechnology & Genetic Engineering Reviews
Volume 34, Issue 1, Pages 122-138
Publisher
Informa UK Limited
Online
2018-05-21
DOI
10.1080/02648725.2018.1474320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current views on the potential for development of a HIV vaccine
- (2017) Kristen W. Cohen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity
- (2017) Dillon Betancourt et al. JOURNAL OF IMMUNOLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
- (2017) Stephen B. Kennedy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
- (2017) Dae-Sun Kim et al. Nature Communications
- Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial
- (2017) Selidji T. Agnandji et al. PLOS MEDICINE
- Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose
- (2017) Ming Zhang et al. Frontiers in Cellular and Infection Microbiology
- Customized Viral Immunotherapy for HPV-Associated Cancer
- (2017) Matthew J. Atherton et al. Cancer Immunology Research
- Cancer Vaccines
- (2016) Shamayel Mohammed et al. ADVANCES IN ANATOMIC PATHOLOGY
- Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
- (2016) E Ilett et al. GENE THERAPY
- Efficacy of Vesicular Stomatitis Virus–Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona
- (2016) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
- (2016) Surender Khurana et al. NATURE MEDICINE
- Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment
- (2016) David K. Clarke et al. VACCINE
- Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
- (2015) Demetrius Matassov et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains
- (2015) Alex B. Ryder et al. JOURNAL OF VIROLOGY
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
- (2015) Chad E. Mire et al. NATURE
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
- (2015) Jonathan D. Fuchs et al. Open Forum Infectious Diseases
- Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman Primates
- (2014) D. K. Clarke et al. JOURNAL OF VIROLOGY
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- After 2015: infectious diseases in a new era of health and development
- (2014) C. Dye PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis
- (2014) Fei Wu et al. VACCINE
- Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters
- (2014) Joseph Prescott et al. Viruses-Basel
- Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters
- (2013) Michael K. Lo et al. ANTIVIRAL RESEARCH
- Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial Virus
- (2013) J. E. Eyles et al. JOURNAL OF INFECTIOUS DISEASES
- Maraba Virus as a Potent Oncolytic Vaccine Vector
- (2013) Jonathan G Pol et al. MOLECULAR THERAPY
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+T-cell responses to anticancer vaccines
- (2013) Byram W Bridle et al. OncoImmunology
- Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-cell Transfer
- (2012) D. M. Rommelfanger et al. CANCER RESEARCH
- A Chimeric Vesiculo/Alphavirus Is an Effective Alphavirus Vaccine
- (2012) A. Chattopadhyay et al. JOURNAL OF VIROLOGY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Targeting the tumor mutanome for personalized vaccination therapy
- (2012) Sebastian Kreiter et al. OncoImmunology
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Significant Protection against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen
- (2011) J. B. Schell et al. JOURNAL OF VIROLOGY
- Combining oncolytic virotherapy and tumour vaccination
- (2010) Byram W. Bridle et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus
- (2010) Jan Brun et al. MOLECULAR THERAPY
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
- (2009) Byram W Bridle et al. MOLECULAR THERAPY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge
- (2009) John Schell et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search